α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes

P. A. Gottlieb; A. K. Alkanani; A. W. Michels; E. C. Lewis; L. Shapiro; C. A. Dinarello; D. Zipris

doi:10.1089/dia.2015.1510

α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes

P. A. Gottlieb, A. K. Alkanani, A. W. Michels, E. C. Lewis, L. Shapiro, C. A. Dinarello, D. Zipris

Department of Clinical Biochemistry and Pharmacology

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Original language	English
Pages (from-to)	S86-S87
Journal	Diabetes Technology and Therapeutics
Volume	17
DOIs	https://doi.org/10.1089/dia.2015.1510
State	Published - 1 Feb 2015

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology
Medical Laboratory Technology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1089/dia.2015.1510

Cite this

Gottlieb, P. A., Alkanani, A. K., Michels, A. W., Lewis, E. C., Shapiro, L., Dinarello, C. A., & Zipris, D. (2015). α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes. Diabetes Technology and Therapeutics, 17, S86-S87. https://doi.org/10.1089/dia.2015.1510

@article{5024d7053e8a4c8bbe32736c3faa8c30,

title = "α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes",

author = "Gottlieb, {P. A.} and Alkanani, {A. K.} and Michels, {A. W.} and Lewis, {E. C.} and L. Shapiro and Dinarello, {C. A.} and D. Zipris",

year = "2015",

month = feb,

day = "1",

doi = "10.1089/dia.2015.1510",

language = "English",

volume = "17",

pages = "S86--S87",

journal = "Diabetes Technology and Therapeutics",

issn = "1520-9156",

publisher = "Mary Ann Liebert Inc.",

}

Gottlieb, PA, Alkanani, AK, Michels, AW, Lewis, EC, Shapiro, L, Dinarello, CA & Zipris, D 2015, 'α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes', Diabetes Technology and Therapeutics, vol. 17, pp. S86-S87. https://doi.org/10.1089/dia.2015.1510

α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes. / Gottlieb, P. A.; Alkanani, A. K.; Michels, A. W. et al.
In: Diabetes Technology and Therapeutics, Vol. 17, 01.02.2015, p. S86-S87.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes

AU - Gottlieb, P. A.

AU - Alkanani, A. K.

AU - Michels, A. W.

AU - Lewis, E. C.

AU - Shapiro, L.

AU - Dinarello, C. A.

AU - Zipris, D.

PY - 2015/2/1

Y1 - 2015/2/1

UR - http://www.scopus.com/inward/record.url?scp=84923112428&partnerID=8YFLogxK

U2 - 10.1089/dia.2015.1510

DO - 10.1089/dia.2015.1510

M3 - Comment/debate

C2 - 25679434

AN - SCOPUS:84923112428

SN - 1520-9156

VL - 17

SP - S86-S87

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

ER -

Gottlieb PA, Alkanani AK, Michels AW, Lewis EC, Shapiro L, Dinarello CA et al. α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes. Diabetes Technology and Therapeutics. 2015 Feb 1;17:S86-S87. doi: 10.1089/dia.2015.1510

α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this